Comparison of two forms of continuous combined hormone replacement therapy with respect to metabolic effects

Abstract

To compare the metabolic effects of two frequently used continuous hormone replacement therapies. Two hundred and forty-six menopausal women, aged between 41 and 57 years were enrolled in the present study. They were randomized to receive either estrogen + 2.5 mg medroxyprogesterone acetate (CEE/MPA) or 1 mg 17 <beta> estradiol + 0.5 mg norethindrone… (More)
DOI: 10.1007/s00404-006-0265-5

3 Figures and Tables

Topics

  • Presentations referencing similar topics